
The EHR Dark Data Goldmine: Why Sentence-Level Provenance Is Pharma's New Real-World Evidence Moat
Dr. Dereck Mush, MD, MBANo. 0 Researchers & academics
Director, Division of Hematology, Ohio State University Comprehensive Cancer Center • United States
Leukemia researcher whose trials reshaped how chronic lymphocytic leukemia is treated.
Find on LinkedInWoyach leads hematology at one of the largest cancer centers in the United States and runs practice-changing trials in CLL, making her one of the most cited voices in blood cancer research and a frequent presence at major oncology meetings.
Leukemia researcher whose trials reshaped how chronic lymphocytic leukemia is treated.
Woyach leads hematology at one of the largest cancer centers in the United States and runs practice-changing trials in CLL, making her one of the most cited voices in blood cancer research and a frequent presence at major oncology meetings.
Loading the full dossier
Audience size across LinkedIn, X, YouTube, podcasts and newsletters.
How much the audience actually reacts, comments, shares and subscribes.
Clinical, research, operating or investing track record behind the commentary.
Publishing cadence and how reliably they show up with original work.
Whether decision makers, policy and capital actually move on what they say.
Scores are subjective editorial estimates compiled by our research desk from public profiles and published work. They are opinion, not measurement, and they are not a judgement of any person's character or ability.
Change, add or remove details on this profile. Our desk reviews every request.
This profile is compiled by our research desk from public sources and is published as editorial commentary. Want a correction, an update, or your profile removed? and see our corrections and removals policy.

Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBAKeep exploring